On that point—the technical briefing—I hadn't heard of this. If we are going to have it, when would that be? I certainly think that it would be mandatory for all of us to take part in it if we want to understand the subject, because I know this matter is very complex, as Mr. Davies said. There's a PMPRB, but there's a sub-board or something. How do they make their decisions about what to finance?
It is all very technical. It took me an hour talking with pharmaceutical representatives to start to understand how it works, and I've done medicine for 35 years. I would be happy to have that technical briefing outside these hours, but when are we going to have it so it can be arranged?